Transglutaminase IgA Test · Stool

If gluten has ever felt like it disagrees with you, or if anyone in your family has celiac disease, this single blood test answers a question that vague symptoms alone cannot: is your immune system actually attacking your gut every time you eat wheat? A clear yes or no here changes what you put on your plate for the rest of your life.

tTG-IgA (tissue transglutaminase immunoglobulin A) is the antibody your immune system produces when gluten triggers damage to the lining of your small intestine. It is the most accurate single blood test for celiac disease, and at high enough levels it can confirm the diagnosis with near-certainty.

What This Antibody Actually Reflects

Tissue transglutaminase is an enzyme found throughout your body, including the lining of your small intestine, where it chemically modifies gluten fragments after you eat wheat, barley, or rye. In people with celiac disease, the immune system mistakes this enzyme for a threat and produces IgA antibodies against it. Those antibodies are what this test measures.

Circulating tTG-IgA has been described as a hallmark signal of small-intestinal damage caused by gluten ingestion. Higher levels track with more severe flattening of the small intestine's absorptive surface (called villous atrophy), more iron deficiency, more bone density loss, and more digestive symptoms.

Celiac Disease and Gut Damage

The strongest evidence for tTG-IgA is in celiac disease itself. In adults and children eating gluten, the test has about 90 to 98 percent sensitivity and 95 to 99 percent specificity, meaning it correctly flags the vast majority of true cases and rarely raises false alarms. At very high levels (10 times the upper limit of normal or more), the test has roughly 99 to 100 percent specificity, which is high enough that pediatric guidelines and a 2024 adult meta-analysis support diagnosing celiac disease without a biopsy when results are this elevated and the clinical suspicion is moderate to high.

The damage that drives those antibodies is not abstract. People with high tTG-IgA at diagnosis tend to have more severe intestinal injury, worse nutrient absorption, and more pronounced symptoms than those with mildly elevated levels.

Pregnancy and Fetal Growth

In a study of about 7,000 pregnant women, higher maternal tTG-IgA was linked to reduced fetal growth and lower birth weight, with a more pronounced effect in women carrying the HLA-DQ2 or DQ8 genetic patterns associated with celiac disease. A more recent analysis of 1,768 pregnancies found that screening for tTG-IgA in pregnancy identified women at higher risk of poor outcomes for both mother and baby.

What this means for you: if you are planning a pregnancy or currently pregnant and have any personal or family history hint of gluten intolerance, this is one number worth knowing before delivery, not after.

Liver and Skin Conditions

Elevated tTG-IgA also shows up in dermatitis herpetiformis, an intensely itchy skin rash that is essentially celiac disease appearing on the skin, where antibody levels correlate with the extent of underlying small-intestine damage. In a study of 276 adults with alcohol use disorder, tTG-IgA was substantially higher in those with alcohol-related liver disease than in heavy drinkers without liver injury or healthy controls, and the levels tracked with markers of liver inflammation and scarring.

Heart Disease and Mortality

The Mini-Finland Health Survey followed 6,887 adults for a median of 26 years and found no clear link between tTG-IgA positivity and coronary heart disease after adjusting for standard risk factors (hazard ratio 1.04, 95% CI 0.83 to 1.30). A separate Finnish cohort of 6,987 adults followed for up to 28 years found no significant increase in overall mortality with tTG positivity, though there were hints of more deaths from lymphoma, stroke, and respiratory disease that did not reach statistical certainty.

What this means for you: tTG-IgA is best understood as a specific signal of gluten-driven autoimmunity, not a general cardiovascular or longevity marker. Its value is in detecting a treatable condition early, before years of unrecognized gut damage create downstream problems like anemia, osteoporosis, or infertility.

Reference Ranges

These ranges are based on published clinical research and guidelines from the European Society for Paediatric Gastroenterology and the American Gastroenterological Association. Different commercial assays use different units and slightly different cutoffs, so any single number must be interpreted in the context of the specific lab's reference range, not a universal target.

Compare your results within the same lab over time for the most meaningful trend. Switching labs or assay platforms can change the number even when your biology has not changed.

Why One Reading Is Not Enough

A single tTG-IgA result, especially near the cutoff, deserves a second look. Pediatric guidelines explicitly recommend two separate blood samples before making a no-biopsy diagnosis, because transient elevations and technical errors do happen. Around borderline values (roughly 3 to 10 international units per milliliter on common assays), analytical variability between samples can run 30 to 40 percent, enough to flip a result from negative to positive.

For someone newly diagnosed and starting a gluten-free diet, retesting every 3 to 6 months is reasonable to track whether antibody levels are coming down. One study of 1,024 children found that most normalized within 24 months on a strict gluten-free diet. After antibodies return to negative, annual testing is a sensible cadence to catch hidden gluten exposure or non-adherence early.

When Results Can Be Misleading

Several situations can distort a tTG-IgA reading and lead to wrong conclusions:

• Recent gluten avoidance: if you have cut back on gluten in the weeks before testing, your antibodies can drop into the negative range even if you have celiac disease. For diagnostic accuracy, you need to be eating roughly three slices of bread worth of gluten daily for one to three months before the test.
• IgA deficiency: about 1 in 500 people make very little IgA, which makes this entire test class falsely negative. Pairing tTG-IgA with a total IgA measurement, or using IgG-based versions, solves this.
• Type 1 diabetes: people with type 1 diabetes have more false-positive tTG-IgA results, so a mildly elevated number in this group is less likely to mean celiac disease than the same number in someone without diabetes.
• Persistent damage despite normal results: on a gluten-free diet, normal tTG-IgA is a poor proxy for actual gut healing. A meta-analysis found these antibody tests miss roughly half of patients with ongoing intestinal damage. If symptoms persist, biopsy may still be needed.

What to Do With an Abnormal Result

If your tTG-IgA comes back elevated and you have been eating gluten, the next step is not to start a gluten-free diet on your own. That would erase the evidence needed for a definitive diagnosis. Instead, the standard pathway involves measuring endomysial antibodies (EMA) as a confirmatory test, checking total IgA to rule out deficiency, and consulting a gastroenterologist who can decide whether duodenal biopsy is needed.

At levels 10 times the upper limit of normal or higher, combined with a positive EMA, the diagnosis can often be made without biopsy. At lower elevations, biopsy remains the standard. Either way, once celiac disease is confirmed, the next workup typically includes vitamin D, iron studies, vitamin B12, folate, a bone density scan, and screening for associated autoimmune conditions like thyroid disease.